Medicine Supply Notifiction: Dulaglutide (Trulicity® ) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection devices
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Dulaglutide (Trulicity®) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection devices.
MSN/2022/079
Tier 2 – medium impact
Date of issue 30th September 2022
- Supplies of dulaglutide (Trulicity®) 0.75mg, 1.5mg, 3mg and 4.5mg solution for injection devices are limited until January 2023, supply will only be available for existing patients.
- Semaglutide (Ozempic®) is unable to support any uplift in demand (see MSN/2022/080).
- Supplies of alternative parenteral GLP-1 receptor agonists (RAs) remain available.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
